Short-Course Chemotherapy With TMC207 and Rifapentine in a Murine Model of Latent Tuberculosis Infection

American Journal of Respiratory and Critical Care Medicine - United States
doi 10.1164/rccm.201103-0397oc
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Thoracic Society

Related search

Clinical and Genomic Responses to Ultra-Short Course Chemotherapy in Spinal Tuberculosis

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2017English

Guinea Pig Model of Mycobacterium Tuberculosis Latent/Dormant Infection

Microbes and Infection
Infectious DiseasesImmunologyMicrobiology
2008English

Characterization of Host and Microbial Determinants in Individuals With Latent Tuberculosis Infection Using a Human Granuloma Model

mBio
VirologyMicrobiology
2015English

Dose-Ranging Comparison of Rifampin and Rifapentine in Two Pathologically Distinct Murine Models of Tuberculosis

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2012English

Treatment of Latent Tuberculosis Infection

Seminars in Respiratory Infections
2003English

Latent Tuberculosis Infection in Mexican Children With Rheumatic Diseases

Clinical Microbiology and Infectious Diseases
2016English

Treatment of Latent Infection With Mycobacterium Tuberculosis: Update 2010

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2010English

Isoniazid Hepatotoxicity Associated With Treatment of Latent Tuberculosis Infection

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2005English

Treatment Completion for Latent Tuberculosis Infection: A Retrospective Cohort Study Comparing 9 Months of Isoniazid, 4 Months of Rifampin and 3 Months of Isoniazid and Rifapentine

BMC Infectious Diseases
Infectious Diseases
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy